id: minds_based_aws_protocol_implementation_to_benzodiazepine_treatment_duration
name: MINDS-Based Alcohol Withdrawal Syndrome Protocol Implementation â†’ Duration of
  Benzodiazepine Administration
from_node:
  node_id: minds_based_aws_protocol_implementation
  node_name: MINDS-Based Alcohol Withdrawal Syndrome Protocol Implementation
to_node:
  node_id: benzodiazepine_treatment_duration
  node_name: Duration of Benzodiazepine Administration
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Standardized MINDS-based protocol provides objective criteria for initiating
  and discontinuing benzodiazepine therapy'
- 'Step 2: Symptom-triggered approach allows for more responsive adjustment of treatment
  based on clinical trajectory'
- 'Step 3: Clear assessment thresholds enable earlier identification of withdrawal
  symptom resolution'
- 'Step 4: Reduced treatment duration while maintaining adequate symptom control and
  safety'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Kevin M Krcmarik et al. 2023. "Assessment of a modified MINDS-based
    protocol for management of alcohol withdrawal syndrome on an inpatient medical
    service.." *Pharmacotherapy*. https://doi.org/10.1002/phar.2855
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.739217'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: symptom_triggered_therapy_approach
  direction: strengthens
  strength: strong
  description: Symptom-triggered therapy design of protocol enables more dynamic treatment
    adjustment compared to fixed-schedule dosing
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/minds_based_aws_protocol_implementation_to_benzodiazepine_treatment_duration.yaml
_category: healthcare_access
